NEW YORK , Nov. 15, 2021 /PRNewswire/ -- The polyester polyol market is expected to grow by USD 2.24 bn at a CAGR of over 5% from 2019 to 2024, according to the latest research report from Technavio. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The polyester polyol market is segmented by type (aliphatic polyester polyol and aromatic polyester polyol) and geography (APAC, Europe , North America , MEA, and South America ).
Request a Free Sample Report to explore growth opportunities in the polyester polyol market.
The report on the polyester polyol market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The market is driven by the demand from the automotive and construction industries.
The polyester polyol market covers the following areas:
Polyester Polyol Market Sizing Polyester Polyol Market Forecast Polyester Polyol Market Analysis
APAC was the largest geographic segment of the polyester polyol market in 2019, and the region will offer several growth opportunities to market vendors. According to Technavio, APAC will account for 61% of the growth of the market during the forecast period. China , the US, Japan , and South Korea (Republic of Korea) are the key countries for the polyester polyol market in APAC. The growth of the market in APAC is expected to be faster than the growth of the market in other regions. The market in the region will be driven by factors such as the increasing number of residential, non-residential, and public infrastructure projects, especially in India , China , Malaysia , and other developing countries.
Subscribe to our "Lite Plan" billed annually at USD 3000 to view 3 reports monthly and download 3 reports annually.
Biopolymers and Bioplastic Market: The biopolymers and bioplastic market has been segmented by end-user (packaging, consumer goods, and others), type (bio-PE, bio-PET, PLA, biodegradable starch blends, and others), and geography (Europe , APAC, North America , South America , and MEA). Download Free Sample Report
Polyetheramine Market: The polyetheramine market has been segmented by application (epoxy coatings, polyurea, adhesives and sealants, composites, and others) and geography (APAC, Europe , North America , South America , and MEA). Download Free Sample Report
Accelerate at a CAGR of over 5%
APAC, Europe, North America, MEA, and South America
China, US, Germany, Japan, and South Korea (Republic of Korea)
Leading companies, competitive strategies, consumer engagement scope
BASF SE, Covestro AG, DIC Corp., Dow Inc., Huntsman Corp., Kansai Paint Co. Ltd., Kuraray Co. Ltd., Purinova Sp zoo, Stepan Co., and Sumitomo Bakelite Co. Ltd.
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: media@technavio.com Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/usd-2-24-bn-growth-in-polyester-polyol-market-from-2019-to-2024technavio-301423076.html
The drugmaker says its acoramidis trial for ATTR-CM treatment didn't meet primary endpoints, sending the stock plummeting.
Every investor in NIO Inc. ( NYSE:NIO ) should be aware of the most powerful shareholder groups. Generally speaking, as...
As we get ready to turn the page on 2021, I can't help but note how we've witnessed a pretty substantial market bifurcation in stocks over the past couple of quarters. Below are four stocks that I believe are likely to find their way into my portfolio in 2022. A year ago, I was completely against electric vehicle (EV) manufacturer Nio (NYSE: NIO).
Since the Great Recession officially ended in 2009, growth stocks have been the driving force on Wall Street. Low lending rates, massive government spending, and the Federal Reserve providing an abundant pool of cheap capital have incentivized businesses to hire, innovate, and acquire other companies. The chickens are now coming home to roost in terms of runaway inflation, and though the Fed has indicated rate hikes are coming to combat high prices, effects won't be felt right away.
Sorrento Therapeutics Inc. announced Monday a contract for the sale and distribution of up to 10 million its Covistix rapid COVID-19 virus detection tests in Mexico. That follows a previously announced deal for up to 5 million Covistix tests in Mexico, bringing the total number of tests to 15 million. The biopharmaceutical company said independent clinical testing of Covistix by a Mexico-based national institute showed a "very high sensitivity" of around 90% in an "all-comers" population, includ
It's been a dreadful year for Citigroup (NYSE: C) in terms of stock price performance, with shares of the megabank down about 1% this year. The KBW Nasdaq Bank Index, which tracks large bank stocks, is up nearly 35% this year, showing just how much Citigroup has lagged the broader sector. Trading at beaten-down levels, can Citigroup turn it around in 2022?
Investing in stocks can be a risky endeavor. Buying a stock does not guarantee an investor a return on that investment. For that matter, it does not even guarantee an investor a return of their initial investment.
2021 was a mixed bag for the renewable energy industry, but investors should stay focused on the companies in this space that have what it takes to be winners over the long haul.
The dividends for such stocks are pretty much their only attraction. On the other hand, you can find dividend stocks that are anything but boring and stodgy. Here are three dividend stocks that soared more than 50% in 2021 and are still great buys.
If you have $100 at the ready not needed for bills or emergencies and a brokerage that allows fractional share purchases, you have enough to buy into the following pair of no-brainer stocks right now. Palantir Technologies (NYSE: PLTR) is the Liam Neeson of data analytics stocks: It has a very particular set of skills that were acquired over a very long career. The U.S. military is also a prime customer, using Palantir's technology to coordinate millions of troops around the world.
When you leave a job, and an IRA rollover is only one way to preserve the money’s tax-deferred status, and it's not always the best.
Chinese citizens lashed out online against billionaire Tesla founder Elon Musk's space ambitions on Monday after China complained that its space station was forced to take evasive action to avoid collision with satellites launched by Musk's Starlink programme. The satellites from Starlink Internet Services, a division of Musk's SpaceX aerospace company, had two "close encounters" with the Chinese space station on July 1 and Oct. 21, according to a document submitted by China earlier this month to the U.N.'s space agency.
In the last batch, taxpayers got close to $1,200 back, on average.
Abbott Laboratories (NYSE: ABT) shares have gained around 26% in 2021. Despite the big payout bumps, Abbott only needed around 33% of the free cash flow its operations generated over the past year to make dividend payments. Despite pandemic pressure, medical-device segment sales during the first nine months of 2021 rose 24.5% year over year to $10.6 billion.
What were you expecting? A six-figure allowance?
On Friday, Chinese regulators released a draft of new policies for companies wishing to offer shares in foreign countries. It's not providing much of a boost.
'Rich Dad Poor Dad' is as bearish as ever.
Shares of BridgeBio Pharma Inc. plummeted 66.2% in premarket trading Monday, after the drug maker said a Phase 3 study of its acoramidis for the treatment of symptomatic transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM) failed to meet its primary endpoint at Month 12. The company said the decline observed in both arms of the study was similar to expected functional decline in healthy elderly adults, and were also "substantially less" than declines observed in previous untreated arms reviewed
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
How to decide whether to start collecting your retirement benefits at age 62, at your full retirement age (FRA), or even later.